Singh Shawn 4
4 · Vistagen Therapeutics, Inc. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2023-06-30$1.59/sh+167$265→ 5,466 total
Holdings
- 20,875(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan ("ESPP").